BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Oct 12, 2023
Distillery Therapeutics

CRISPR editing of ATP2B2 and TMC1 for hearing loss

BioCentury | Jun 17, 2010
Distillery Therapeutics

Indication: Cancer

Items per page:
1 - 3 of 3
Help Center
Username
Request a Demo
Request Training
Ask a Question